Brief: MiNK Announces Preclinical Data Showcasing Activity Of MiNK-215 Against Colorectal Cancer Liver Metastases
06/03/2024 13:51
March 6 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK ANNOUNCES PRECLINICAL DATA SHOWCASING ACTIVITY OF
MINK-215
AGAINST COLORECTAL CANCER LIVER METASTASES AT AACR 2024
Source text for Eikon: ID:nGNX8s9qRW
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's